APA (7th ed.) Citation

N, S., A, C., AD, S., E, C., G, P., P, M., . . . A, K. (2023). Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer. Cellular and molecular life sciences : CMLS, 80(4), 100. https://doi.org/10.1007/s00018-023-04734-7

Chicago Style (17th ed.) Citation

N, Simigdala, et al. "Loss of Kmt2c in Vivo Leads to EMT, Mitochondrial Dysfunction and Improved Response to Lapatinib in Breast Cancer." Cellular and Molecular Life Sciences : CMLS 80, no. 4 (2023): 100. https://doi.org/10.1007/s00018-023-04734-7.

MLA (9th ed.) Citation

N, Simigdala, et al. "Loss of Kmt2c in Vivo Leads to EMT, Mitochondrial Dysfunction and Improved Response to Lapatinib in Breast Cancer." Cellular and Molecular Life Sciences : CMLS, vol. 80, no. 4, 2023, p. 100, https://doi.org/10.1007/s00018-023-04734-7.